NextPlat (NXPL) Shares Outstanding (Diluted) (2014 - 2026)
Analysis
NextPlat (NXPL) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 1.17 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 1.16 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 833.33 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 328.10 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 378.10 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 21.92 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 291.34 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 44.23 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 36.43 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 2.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Mar 31, 2026 | 2.69 Mn |
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 2.03 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 959,200.00 |
| Sep 30, 2022 | 946,951.00 |
| Jun 30, 2022 | 929,310.00 |
| Mar 31, 2022 | 1,249.00 |
| Dec 31, 2021 | 1,249.00 |
| Sep 30, 2021 | 1,249.00 |